AI case study

Novo NordiskClinical data insights

Silos forced teams to manually chase data. Now, AI agents identify adverse events in seconds, eliminating weeks of cross-referencing.

Published

Key results

Projected New Value
$157M+
Projected Efficiency Gains
$14M+

Result highlights

Unlock 3 result highlights

The story

Context

A century-old global pharmaceutical company generating billions of data points from clinical trials across diabetes, obesity, and chronic disease research, with over 60 teams operating across eight cloud regions.

Challenge

Clinical trial data lived in a 'patchwork spiderweb' of fragmented, individually managed storage solutions, with no single person holding knowledge...

Solution
Unlock full story

Scope & timeline

  • 9-month concept-to-MVP deployment
  • 1,000 users actively engaging with FounData
  • Clinical data adoption up from ~1% to 20%+ of dev org

Quotes

Unlock 45 more quotes

The company

Novo Nordisk logo

Novo Nordisk

novonordisk.com

Pharmaceutical company specializing in diabetes, obesity, and rare blood disorders.

IndustryPharmaceuticals & Biotech
LocationBagsværd, Denmark
Employees50K-100K
Founded1923

The vendor

Databricks is a Big Data company that offers a unified analytics platform for data science, engineering, and analytics teams.

IndustrySoftware & Platforms
LocationSan Francisco, California, United States
Employees10K-50K
Founded2013

Use case

Novo Nordisk's Clinical data insights is part of this use case:

Scientific Discovery
22 case studies(+114% YoY)
Proven impact?
LowModerateVery Strong
4.7Moderate
4.9Moderatewithin Pharmaceuticals & Biotech
4.5Moderatewithin Product Engineering

Similar Case Studies

Related implementations across industries and use cases

24 AI case studies in Scientific Discovery

98 AI case studies in Pharmaceuticals & Biotech

608 AI case studies in Product Engineering